Skip to main content

Table 3 Results of the household survey to screen for persons suspected to have epilepsy

From: Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin

Variables

Overall (N = 971)

Family keeps pigs (n = 971)

 No

836 (83.6%)

 Yes

135 (13.9%)

A family member died from epilepsy (n = 971)

 Don’t know

11 (1.1%)

 No

933 (96.1%)

 Yes

27 (2.8%)

Known to have epilepsy (n = 966)

 Don't know

4 (0.4%)

 No

950 (98.0%)

 Yes

15 (1.5%)

Sudden fall and loss of consciousness (n = 969)

 No

944 (97.4%)

 Yes

25 (2.6%)

If yes, did you have loss of bladder control and/ or foam in the mouth (n = 25)

 

 No

7 (28.0%)

 Yes

18 (72.0%)

Absence(s) or sudden loss(es) of contact with the surroundings, for a short duration of time (n = 969)

 Don't know

1 (0.1%)

 No

948 (97.8%)

 Yes

20 (2.1%)

Sudden, uncontrollable twitching or shaking of your arms, legs or head, for a period of a few minutes (n = 968)

 Don't know

1 (0.1%)

 No

945 (97.5%)

 Yes

23 (2.4%)

Sudden and brief bodily sensations, see or hear things that are not there, or smell strange odours (n = 966)

 Don't Know

3 (0.3%)

 No

950 (98.3%)

 Yes

13 (1.3%)

Took ivermectin during the last distribution in March 2021 (n = 967)

 Don't Know

18 (1.9%)

 No

338 (36.8%)

 Yes

611 (63.2%)

Mean (range) number of total rounds of ivermectin taken by age groups (n = 967)

 5‒30 years

5.21 (0‒20)

 31‒60 years

10.3 (0‒40)

 > 60 years

14.2 (0‒35)

 Overall

7.7 (0‒40)

Epilepsy prevalence according to duration of residence in the community (n = 969)

 Resident for < 15 years

1.9% (6/311)

 Resident for ≥ 15 years

1.3% (9/658)

Epilepsy prevalence according to District

(n = 969)

 Tain

1.6% (7/439)

 Wenchi

1.5% (8/530)